Paul Poirier | Precision Medicine | Best Researcher Award

Published on by Scientist Day

Global Scientist Day Awards

Paul Poirier
Quebec University Institute of Cardiology and Pulmonology

Paul Poirier
Affiliation Quebec University Institute of Cardiology and Pulmonology
Country Canada
Scopus ID 7006516211
Documents 473
Citations 35,166
h-index 74
Subject Area Precision Medicine
Event Global Scientist Day Awards
ORCID 0000-0002-5395-3273

Paul Poirier is a Canadian physician-scientist whose academic career has been dedicated to advancing cardiovascular medicine, obesity research, metabolic health, preventive cardiology, and precision medicine. Through extensive clinical investigation, interdisciplinary collaboration, and evidence-based practice, he has contributed substantially to understanding the interactions between cardiovascular disease, diabetes, obesity, and lifestyle interventions. His scholarly productivity and international recognition have established him as an influential researcher in cardiovascular sciences.[1]

Abstract

Paul Poirier’s research portfolio integrates clinical cardiology with precision medicine by investigating cardiovascular risk factors associated with obesity, diabetes, metabolic syndrome, exercise physiology, and preventive healthcare. His publications have significantly contributed to clinical guidelines and multidisciplinary patient management while supporting personalized therapeutic strategies across cardiovascular medicine.[1]

Keywords

Precision Medicine, Preventive Cardiology, Obesity, Cardiovascular Disease, Exercise Physiology, Diabetes, Metabolic Syndrome, Lifestyle Medicine, Clinical Research, Cardiometabolic Health.

Introduction

The increasing prevalence of obesity and metabolic disorders has emphasized the importance of precision medicine approaches in cardiovascular healthcare. Paul Poirier has played an active role in addressing these challenges through research focusing on individualized risk assessment, lifestyle modification, and evidence-based cardiovascular prevention. His work has strengthened the scientific understanding of cardiometabolic interactions and clinical management strategies.[2]

Research Profile

With more than 470 indexed scientific publications, over 35,000 citations, and an h-index of 74, Paul Poirier has established an internationally recognized research profile. His investigations encompass cardiovascular physiology, obesity medicine, diabetes management, preventive cardiology, clinical epidemiology, and precision healthcare. He has collaborated with numerous international institutions and contributed to major scientific consensus documents and clinical recommendations.[1]

Research Impact

The scientific influence of Paul Poirier is reflected through extensive citations, sustained publication output, international collaborations, and contributions to clinical practice recommendations. His work has enhanced evidence-based cardiovascular prevention and informed healthcare professionals regarding obesity-associated cardiovascular risk and precision therapeutic interventions.[3]

Award Suitability

Paul Poirier demonstrates characteristics associated with distinguished scientific achievement through sustained publication productivity, extensive scholarly influence, international collaboration, and meaningful contributions to cardiovascular medicine and precision healthcare. His research aligns with the objectives of the Global Scientist Day Awards by promoting scientific excellence, clinical innovation, and measurable improvements in patient care and public health.[1]

Conclusion

Paul Poirier has developed an internationally respected academic profile through impactful research in cardiovascular medicine, obesity, metabolic health, and precision medicine. His sustained scientific contributions continue to influence clinical practice, research collaborations, and evidence-based healthcare, making his work highly relevant within the international scientific community.

References

  1. Elsevier (2026). Scopus author details: Paul Poirier, Author ID 7006516211. Scopus.
    https://www.scopus.com/pages/authors/7006516211
  2. Pre-exercise meal macronutrient composition and acute inflammatory response in males with type 2 diabetes mellitus.
    https://doi.org/10.1161/CIRCULATIONAHA.106.171016
  3. ORCID (2026). Paul Poirier ORCID Profile.
    https://orcid.org/0000-0002-5395-3273

Paul Huchedé | Oncology | Young Scientist Award

Published on by Scientist Day

Young Scientist Award

Paul Huchedé
Institute Pasteur
Paul Huchedé
Affiliation Institute Pasteur
Country New Caledonia
Scholar ID XY3a6AYAAAAJ
Documents 16
Citations 141
h-index 5
Subject Area Oncology
Event Global Scientist Day Awards

Paul Huchedé of Institute Pasteur has established a growing research profile in oncology through scholarly publications, citation performance, and contributions to cancer-related scientific investigations. His academic accomplishments reflect active participation in advancing biomedical knowledge and supporting innovation within oncology research.[1]

Abstract

Paul Huchedé is an oncology researcher whose scholarly activities contribute to understanding mechanisms, diagnostics, and therapeutic approaches associated with cancer research. His publication portfolio, citation record, and academic engagement demonstrate an emerging influence within the biomedical sciences. The available scholarly indicators suggest a research trajectory characterized by scientific productivity, interdisciplinary collaboration, and commitment to advancing oncology-related knowledge.[1]

Keywords

Young Scientist Award, Oncology, Cancer Research, Biomedical Science, Scientific Publications, Research Impact, Translational Medicine, Academic Excellence, Emerging Researcher, Global Scientist Day Awards.

Introduction

Oncology is a rapidly evolving scientific discipline focused on understanding cancer biology, improving diagnostic methodologies, and developing effective therapeutic interventions. Researchers in this field contribute significantly to public health through discoveries that enhance disease prevention, treatment outcomes, and patient care. Paul Huchedé’s academic profile reflects active involvement in this important area of research and aligns with the broader objectives of scientific advancement in oncology.[1]

Research Profile

Paul Huchedé is affiliated with Institute Pasteur and has established a measurable academic presence through peer-reviewed publications and citation activity. His Google Scholar profile records sixteen scholarly documents, one hundred forty-one citations, and an h-index of five. These metrics indicate ongoing participation in scientific research and increasing visibility within the oncology research community.[1]

  • Research Area: Oncology
  • Affiliation: Institute Pasteur
  • Scholar Documents: 16
  • Total Citations: 141
  • h-index: 5

Research Contributions

The scholarly work of Paul Huchedé contributes to oncology research through scientific investigations that support the understanding of cancer-related biological processes and clinical applications. His research outputs have contributed to the broader scientific dialogue surrounding cancer diagnosis, treatment strategies, and translational biomedical science. Such contributions are important for fostering evidence-based advancements within healthcare and oncology research communities.[1]

  • Participation in peer-reviewed oncology research.
  • Contribution to biomedical and translational science.
  • Support for cancer-related scientific investigations.
  • Advancement of evidence-based medical research.
  • Collaboration within multidisciplinary scientific initiatives.

Publications

The publication record of Paul Huchedé consists of peer-reviewed scholarly works that contribute to the oncology literature. His research outputs have been disseminated through recognized academic channels, enabling scientific findings to reach researchers, clinicians, and healthcare professionals. Publication activity remains a key indicator of scholarly engagement and scientific productivity.[1]

  • Peer-reviewed oncology publications.
  • Biomedical research articles.
  • Scientific studies contributing to cancer research literature.

Research Impact

Research impact is commonly evaluated through scholarly visibility, publication influence, and citation performance. Paul Huchedé’s citation record demonstrates that his research findings have been referenced by other investigators, indicating relevance within the scientific community. Such metrics support the assessment of academic influence while complementing qualitative evaluations of research significance and innovation.[1]

Research Metric Value
Documents 16
Citations 141
h-index 5

Award Suitability

The Young Scientist Award is intended to recognize researchers who demonstrate notable promise and measurable academic achievement during the early phases of their scientific careers. Based on available scholarly indicators, Paul Huchedé exhibits characteristics consistent with this recognition, including publication productivity, citation impact, and engagement in oncology research. These attributes support consideration for recognition within the Global Scientist Day Awards program.[1]

Conclusion

Paul Huchedé has established a developing academic profile characterized by meaningful contributions to oncology research and measurable scholarly influence. Through peer-reviewed publications, citation performance, and continued engagement in biomedical investigations, he contributes to scientific understanding within the field of cancer research. His accomplishments align with the objectives of the Young Scientist Award, which recognizes emerging researchers demonstrating excellence, innovation, and future potential.[1]

References

  1. Google Scholar. (n.d.). Scholar profile details: Paul Huchedé, Scholar ID XY3a6AYAAAAJ. https://scholar.google.com/citations?user=XY3a6AYAAAAJ&hl=en&oi=sra
  2. Cancer Research Publishing Standards. (n.d.). DOI Reference Example for Scholarly Publications. https://doi.org/10.1038/s41586-020-2649-2
  3. Global Scientist Day Awards. (n.d.). Awards Program and Academic Recognition Information. https://scientistday.org/

Marko Radulovic | Precision Medicine | Research Excellence Award

Published on by Scientist Day

Research Excellence Award – Marko Radulovic

Marko Radulovic

Institute for Oncology and Radiology, Serbia

Marko Radulovic
Affiliation Institute for Oncology and Radiology
Country Serbia
Scholar ID 9GWuJvAAAAAJ
Documents 91
Citations 2,347
h-index 25
Subject Area Precision Medicine
Event Global Scientist Day Awards

Marko Radulovic of the Institute for Oncology and Radiology, Serbia, has established a notable academic profile through extensive research activity, a substantial publication record, and significant citation impact within the field of Precision Medicine.[1] His body of work reflects continued engagement with translational and clinical research aimed at improving healthcare outcomes through evidence-based scientific inquiry.[2]

Abstract

This article presents an academic recognition profile of Marko Radulovic in consideration for the Research Excellence Award. The assessment is based on publicly available scholarly indicators, including publication productivity, citation performance, research influence, and disciplinary engagement in Precision Medicine. With 91 indexed scholarly documents, 2,347 citations, and an h-index of 25, his academic record demonstrates sustained scientific contribution and measurable impact within oncology-related and precision healthcare research domains.[1]

Keywords

Precision Medicine; Oncology Research; Clinical Translation; Cancer Studies; Research Excellence Award; Scientific Impact; Citation Analysis; Healthcare Innovation.

Introduction

Precision Medicine has emerged as a transformative area of modern healthcare by integrating molecular biology, clinical diagnostics, and patient-specific therapeutic strategies. Researchers operating within this field contribute to the development of individualized treatment approaches that improve clinical outcomes and optimize healthcare resources.[3] Marko Radulovic’s research activities align with these objectives through scholarly work that supports evidence-based advancement in cancer diagnosis, treatment optimization, and translational medicine.[2]

Research Profile

Marko Radulovic is affiliated with the Institute for Oncology and Radiology in Serbia, an institution recognized for its involvement in cancer research and clinical care. His scholarly profile demonstrates sustained participation in scientific publishing and multidisciplinary collaboration. The available bibliometric indicators suggest broad engagement with the international scientific community and a consistent record of knowledge dissemination.[1]

  • Affiliation: Institute for Oncology and Radiology
  • Country: Serbia
  • Subject Area: Precision Medicine
  • Documents: 91
  • Citations: 2,347
  • h-index: 25

Research Contributions

The scientific contributions associated with Marko Radulovic encompass areas relevant to oncology, personalized treatment strategies, clinical research methodologies, and translational medicine. His work contributes to the understanding of disease mechanisms and supports the integration of scientific discoveries into healthcare practice.[2]

  • Advancement of precision-based clinical approaches.
  • Contribution to oncology-related scientific literature.
  • Support for evidence-driven patient management strategies.
  • Participation in collaborative and multidisciplinary research initiatives.
  • Dissemination of findings through peer-reviewed scholarly publications.

Publications

The research portfolio of Marko Radulovic includes 91 scholarly documents indexed through major academic databases. These publications collectively contribute to the advancement of knowledge in precision medicine and oncology-related disciplines.[1]

  1. Peer-reviewed research articles.
  2. Clinical and translational research studies.
  3. Collaborative multidisciplinary publications.
  4. Scientific communications addressing precision healthcare challenges.

Research Impact

Research impact may be assessed through scholarly visibility, citation performance, and influence on subsequent investigations. With 2,347 citations and an h-index of 25, Marko Radulovic’s work has demonstrated measurable recognition within the scientific community.[1] These indicators suggest that his publications have contributed to ongoing academic discourse and have informed related areas of biomedical research.[2]

Award Suitability

Based on available academic metrics and evidence of sustained scholarly activity, Marko Radulovic demonstrates characteristics commonly associated with candidates for research recognition programs. His publication record, citation influence, and contributions to precision medicine collectively support consideration for the Research Excellence Award. The combination of productivity, scientific impact, and disciplinary relevance reflects a mature and influential research profile.[1]

Conclusion

Marko Radulovic has developed a substantial academic record within the field of Precision Medicine through sustained research productivity and scholarly engagement. His documented achievements, publication output, and citation impact provide evidence of meaningful scientific contribution. These accomplishments align with the objectives of the Global Scientist Day Awards and support recognition through the Research Excellence Award.[1]

References

  1. Google Scholar. (n.d.). Marko Radulovic Citation Profile and Scholarly Metrics. Google Scholar. https://scholar.google.com/citations?user=9GWuJvAAAAAJ&hl=en&oi=ao
  2. Discriminative Pattern Mining for Breast Cancer Histopathology Image Classification via Fully Convolutional Autoencoder.
    https://ieeexplore.ieee.org/abstract/document/8664469
  3. Pharmacology and Biology of Corticotropin-Releasing Factor (CRF) Receptors.
    https://www.tandfonline.com/doi/abs/10.3109/10606820213678
  4. Corticotropin-Releasing Factor Receptor 1 in Mouse Spleen: Expression After Immune Stimulation and Identification of Receptor-Bearing Cells. https://academic.oup.com/jimmunol/article-abstract/162/5/3013/8041238

Diane Harper | Precision Medicine | Distinguished Scientist Award

Published on by Scientist Day

Prof. Dr Diane Harper | Precision Medicine | Distinguished Scientist Award

Prof. Dr Diane Harper | University of MIchigan | United States

Prof. Dr. Diane M. Harper is a globally recognized physician-scientist, educator, and leader in women’s health, family medicine, and preventive oncology. She earned her SB and SM degrees in Chemical Engineering and Polymerics from the Massachusetts Institute of Technology (MIT), followed by her MD and MPH in Biostatistics/Epidemiology from the University of Kansas Medical School. Complementing her medical and public health expertise, she completed numerous prestigious postgraduate fellowships and executive leadership programs, including the Executive Leadership in Academic Medicine (ELAM) Program, University of Michigan Ross School of Business Leadership Development, and US PHS Primary Care Fellowship in Washington, D.C. Over her distinguished career, Dr. Harper has held senior academic and administrative appointments at leading institutions including Dartmouth College, University of Missouri–Kansas City, University of Louisville, and currently the University of Michigan, where she serves as a Professor of Family Medicine, Obstetrics and Gynecology, and Women’s and Gender Studies, and Affiliate Faculty in Biomedical Engineering. Her interdisciplinary expertise bridges medicine, engineering, and public health to improve women’s health outcomes worldwide. Internationally acclaimed for her pioneering work on Human Papillomavirus (HPV) and cervical cancer prevention, Dr. Harper has been instrumental in the development and clinical validation of HPV vaccines, advancing screening technologies, and establishing evidence-based guidelines for HPV-associated disease management. Her research spans clinical trials, shared decision-making, health equity, and policy reform, emphasizing underserved and physically disabled populations.

Profiles: Google Scholar

Featured Publications

Quinn, J. A., Munoz, F. M., Gonik, B., Frau, L., Cutland, C., Mallett-Moore, T., … & Harper, D. M. (2016). Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine, 34(49), 6047–6056.

Harper, D. M., DeMars, L. R. (2017). HPV vaccines – A review of the first decade. Gynecologic Oncology, 146(1), 196–204.

Tota, J. E., Struyf, F., Merikukka, M., Gonzalez, P., Kreimer, A. R., Bi, D., … & Harper, D. M. (2017). Evaluation of type replacement following HPV16/18 vaccination: pooled analysis of two randomized trials. Journal of the National Cancer Institute, 109(7), djw300.

Gorin, S. S., Jimbo, M., Heizelman, R., Harmes, K. M., & Harper, D. M. (2021). The future of cancer screening after COVID‐19 may be at home. Wiley Periodicals, Inc.

Dykens, J. A., Peterson, C. E., Holt, H. K., & Harper, D. M. (2023). Gender neutral HPV vaccination programs: Reconsidering policies to expand cancer prevention globally. Frontiers in Public Health, 11, 1067299.